JAMA发表584例随机对照试验:多巴酚丁胺联合去甲肾上腺素减少脓毒症休克术后肾损伤
Heart drug combo reduces kidney damage in septic shock surgery, major trial finds
一项在中国39家医院纳入584例成人手术患者的随机对照试验显示,脓毒症休克术中在去甲肾上腺素基础上加用多巴酚丁胺,术后一周内新发或加重肾损伤者不足四分之一,对照组约为35%。研究团队称中重度肾损伤约减半,联合组术后首日尿量更多、器官应激表现更轻。联合组心动过速发生率为41%,对照组约30%,但心脏骤停或心律失常等严重并发症未见增加,结果发表于JAMA。
584例脓毒症休克手术患者的随机对照试验显示,加用多巴酚丁胺使中重度肾损伤约减半,同时心动过速更常见。
A simple adjustment to drugs given during operations for septic shock could prevent thousands of patients from suffering kidney damage, according to the results of a major trial now published in JAMA. Scientists from the University of Southampton working with experts from Zhejiang University School of Medicine in China discovered that combining the medications dobutamine and norepinephrine during surgery can significantly lower the risk of acute kidney injury.
Septic shock has a global death rate as high as 50% and is often triggered by an extreme immune response to an infection. Although emergency surgery usually clears the underlying infection, inflammation and surgical trauma can cause kidney injury among patients.
Dr. Nazrul Islam from Southampton, a senior co-corresponding author, said that standard medical care during septic shock surgery is to use blood pressure drugs that can accidentally starve the kidneys of vital blood. "Our trial discovered that adding these two heart medications during the operation safely boosts blood flow. It also significantly cuts the risk of severe kidney damage, offering a safer way to protect vulnerable patients during high-risk surgery."
As part of the trial, experts tracked 584 adult patients undergoing surgery across 39 hospitals in China. Half received an infusion of dobutamine, a heart medication that improves blood flow, alongside norepinephrine, while the other group received norepinephrine alone.
Primary corresponding author Dr. Xiangming Fang, from the Zhejiang University School of Medicine, said, "Our research is timely as the International Guidelines for Management of Sepsis and Septic Shock recently said there was insufficient data to make a recommendation for the use of dobutamine. Clearly this can now be changed—and we hope our findings can help doctors rethink how they care for patients during high-risk emergency surgery."
Results showed that fewer than a quarter of patients given the drug combination developed new or worsening kidney injuries within a week after surgery. This compared to around 35% in the standard care group.
Other results found that the dobutamine and norepinephrine combo triggered more frequent bouts of temporarily elevated heart rate, or tachycardia, affecting 41% of patients compared to about 30% in the other group. However, the researchers found no increase in serious complications, such as cardiac arrest or arrhythmias.
Dr. Lihua Chu from Zhejiang University School of Medicine said, "Crucially, we found the therapy was most effective at preventing serious forms of kidney injuries. Moderate to severe kidney injuries were roughly halved among patients receiving the combined drugs. Patients taking the drug combination produced more urine right away and showed milder overall signs of organ strain during their first day in intensive care."
Publication details
Caixia Li et al., Intraoperative Dobutamine Plus Norepinephrine to Prevent Postoperative Acute Kidney Injury in Septic Shock, JAMA (2026). DOI: 10.1001/jama.2026.21322
Journal information: Journal of the American Medical Association
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Heart drug combo reduces kidney damage in septic shock surgery, major trial finds (2026, October 26) retrieved 26 October 2026 from https://medicalxpress.com/news/2026-10-heart-drug-combo-kidney-septic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com